| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |